Publications & Speeches

Whistleblower Programmes: Making Cartel Detection more Effective

Mary Inman’s article, “Whistleblower Programmes: Making Cartel Detection more Effective” is published in August issue of Financier Worldwide. See the article here!

A Wolf in Sheep's Clothing: the Government's Latest Stand against Patient Kickbacks Disguised as Charity

Mary Inman and Max Voldman were published in the RAC Monitor (July 29, 2020).

Collateral Consequences of Agency Action

Partner Allison Sheedy was a panelist on the ABA Antitrust Section Program Collateral Consequences of Agency Action, focusing on what happens after an agency investigation, including compliance with consent decrees and follow-on civil litigation.  (July 7, 2020) Click here to read more.

Constantine Cannon Attorneys Provide Comments on Model Whistleblower Award and Protection Act

The North American Securities Administrators Association (NASAA) has proposed a Model Whistleblower Award and Protection Act that would serve as a guide for states across North America who wish to enact a compelling whistleblower program to bolster their securities enforcement.  In May, NASAA solicited comments on an initial draft of the Model Act.  Click here to read the Comments by: Eric Havian, Michael Ronickher, and Chris McLamb.  (June 30, 2020)

What the Bostock Decision Teaches About the DMCA

Seth Greenstein was published in Disruptive Competition Project (June 23, 2020).  Click here to read the article.

Fraud in the Time of COVID-19: Pharmaceuticals, Biologics, and Devices

On Jun. 11, Hamsa Mahendranathan appeared on a virtual panel titled "Fraud in the Time of COVID-19: Pharmaceuticals, Biologics, and Devices" sponsored by TAF.

Rebalancing DMCA: Good Bumper Sticker, Bad Public Policy

Seth Greenstein was published in Law360 (June 10, 2020).  Click here to read the article.    

Integra Med Analytics Loses Battle to establish New Breed of Corporate Whistleblower Outsiders

Mary Inman and Max Voldman were published in the RAC Monitor (June 3, 2020).  Click here to read the article.  

Whistleblowers: The Science Sleuths Holding Fraudulent Research Accountable

Mary Inman authored the introduction to an article in Good10: The Pandemic Issue, a collaboration among GOOD, leapsmag, and the Aspen Institute Science & Society Program.

Exemptions, Immunities & Antitrust - Conflict of Laws?

Partner Allison Sheedy spoke on the ABA Antitrust Section Program titled Exemptions, Immunities & Antitrust - Conflict of Laws?, focusing on the doctrines of state action immunity, federal preemption, and good faith regulatory compliance, how the doctrines intersect and whether their policies conflict with antitrust goals. (May 12, 2020) Click here to read more.